.Merck defeats revenues desires, increases purchases outlook on strong need for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Revenue Forecasts as Keytruda Sales Increase BloombergMerck Supply: Pharma Giant Posts Solid Outcomes, But Expectation Drops Short Real estate investor's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats revenue as well as purchases expectations amidst Keytruda advantage, but gives combined full-year expectation MarketWatch.